What are the potential complications of having hypothyroidism (underactive thyroid) and a meningioma (brain tumor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 4, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Complications of Hypothyroidism and Meningioma

Patients with both hypothyroidism and meningioma face significant risks of endocrine dysfunction, neurological complications, and treatment-related adverse effects that require careful monitoring and management.

Hypothyroidism Complications

Metabolic and Cardiovascular Complications

  • Fatigue, weight gain, cold intolerance, and constipation due to decreased metabolic rate 1
  • Increased risk of cardiovascular complications including:
    • Diastolic hypertension
    • Narrowed pulse pressure
    • Potential heart failure in severe, long-standing cases 2

Neurological and Cognitive Effects

  • Cognitive decline and mental status changes
  • Potential for myxedema coma in severe untreated cases 1
  • Exacerbation of neurological symptoms from meningioma due to metabolic effects

Meningioma Complications

Direct Tumor Effects

  • Visual disturbances if near optic pathways
  • Headaches and focal neurological deficits depending on location
  • Seizures and cognitive changes from mass effect
  • Potential for tumor growth and increased intracranial pressure

Treatment-Related Complications

Surgical Complications

  • Hypoparathyroidism (2.6% permanent risk after total thyroidectomy) 2
  • Recurrent laryngeal nerve injury (3% risk after total thyroidectomy) 2
  • Risk varies by surgeon experience (4.3% overall complication rate with experienced surgeons vs. 16% with less experienced surgeons) 2

Radiation Therapy Complications

  • Increased risk of secondary tumors, particularly in younger patients:
    • 3.34-fold increased risk of malignant brain tumors
    • 4.06-fold increased risk of meningiomas 2
    • Risk increases 2.4-fold for malignant brain tumors and 1.6-fold for meningiomas for every 10 years of younger age 2
  • Radiation necrosis with potential cognitive decline 3
  • Hydrocephalus requiring CSF diversion 3
  • Hypopituitarism (20% risk after sellar/parasellar meningioma radiation) 4
    • Thyroid dysfunction (24%)
    • Adrenal insufficiency (24%)
    • Growth hormone deficiency (19%)
    • Gonadal dysfunction (10%)

Endocrine Complications

Hypopituitarism

  • Can result from meningioma compression of the pituitary or radiation treatment
  • Median time to develop deficiencies ranges from 11 months for growth hormone deficiency to 32 months for adrenal insufficiency 4
  • Dose-dependent relationship with radiation exposure 4

Thyroid-Meningioma Interactions

  • Potential for worsening of hypothyroidism due to pituitary dysfunction
  • Rare cases of metastasis from thyroid carcinoma to meningioma have been reported 5

Management Considerations

Monitoring Requirements

  • Regular thyroid function testing (TSH, free T4)
  • Pituitary function assessment after cranial radiation
  • Visual field testing and neuroimaging for meningioma follow-up
  • Cardiovascular risk assessment

Treatment Adjustments

  • Thyroid hormone replacement dosing may need adjustment due to:
    • Changes in metabolism
    • Interactions with other medications
    • Altered absorption due to surgical interventions

Prevention Strategies

  • Early detection and treatment of hypothyroidism to prevent cardiovascular complications
  • Consideration of stereotactic radiosurgery rather than fractionated radiation therapy when appropriate to minimize normal brain exposure 3
  • Long-term endocrine follow-up for patients receiving cranial radiation 4
  • Multidisciplinary care involving endocrinologists, neurosurgeons, and radiation oncologists 6

The combination of these conditions requires vigilant monitoring for both direct tumor effects and the metabolic consequences of hypothyroidism, with particular attention to potential endocrine dysfunction that may develop years after treatment.

References

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

5
Research

Meningioma with metastasis from follicular carcinoma thyroid.

Indian journal of pathology & microbiology, 2010

6
Guideline

Pituitary Adenoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the best management approach for a 37-year-old female with hypothyroidism, vaginal dryness, constipation, and positive Thyroid Peroxidase (TPO) antibodies, but negative Antinuclear Antibody (ANA) test results?
Which of the following statements regarding hypothyroidism is true?
What is the best approach to manage weight gain in a 63-year-old female with a history of hypothyroidism, currently not on levothyroxine, and normal TSH and free T4 levels?
What is the best treatment for a 55-year-old man with microcytic anemia, potential hypothyroidism, and symptoms of fatigue, depression, and cold intolerance?
What is the next most appropriate step for a 12-year-old boy with chronic right groin pain, hypothyroidism, and normal vital signs, who experiences pain with movement of the hip?
What is the management of central pontine myelinolysis?
What is the difference between L-glutamine (L-glutamine) and glutathione supplementation for gut health and immune function?
What are the management recommendations for patients with VVIR (Ventricular Inhibited Ventricular Paced with Rate Response) stimulation?
What is the mechanism of action of VVIR (Ventricular Pacing with Inhibited Response) stimulation?
What physio exercises are recommended for knee osteoarthritis?
What are the possible causes of death, including cardiac complications, in a patient with hypertension, dyslipidemia, hypothyroidism, meningioma, hypokalemia, and hypocalcemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question